Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds

Life Sciences

Volumn 68, Issue 1, 2000, Pages 29-39

  Richelson, Elliott ^a   Souder, Terry ^a  

^a MAYO CLINIC   (United States)

Author keywords

1 Adrenoceptor; 2 Adrenoceptor; Dopamine D2 receptor; Histamine H1 receptor; Muscarinic receptor; Serotonin 5 HT(1A) receptor; Serotonin 5 HT(2A) receptor

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 2,3,3A,12B TETRAHYDRO 3 METHYL 1H DIBENZO[B,F]OXEPINO[10,11 C]PYRROLE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; BRAIN RECEPTOR; CLOZAPINE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; HISTAMINE H1 RECEPTOR; ILOPERIDONE; KETANSERIN; MELPERONE; MEPYRAMINE; MUSCARINIC RECEPTOR; NEUROLEPTIC AGENT; OLANZAPINE; PALIPERIDONE; PIMOZIDE; PRAZOSIN; QUETIAPINE; RAUWOLSCINE; RISPERIDONE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; SERTINDOLE; SPIPERONE; UNINDEXED DRUG; ZIPRASIDONE; ZOTEPINE;

ARTICLE; DROWSINESS; DRUG POTENCY; DRUG RECEPTOR BINDING; ENDOCRINE DISEASE; EXTRAPYRAMIDAL SYMPTOM; HUMAN; HUMAN TISSUE; LIGAND BINDING; PSYCHOSIS; SEDATION;

ANTIPSYCHOTIC AGENTS; BRAIN; HUMANS; RADIOLIGAND ASSAY; RECEPTORS, DRUG; RECEPTORS, NEUROTRANSMITTER;

EID: 0034711425     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(00)00911-5     Document Type: Article

References (41)

1. Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro
2. Antagonism by neuroleptics of serotonin 5-HT1A and 5-HT2 receptors of normal human brain in vitro
3. Affinity of neuroleptics for D1 receptor of human brain striatum
4. Preclinical pharmacology of neuroleptics: Focus on new generation compounds
5. 2 pK(i) values
6. Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptor binding
7. Pharmacological differentiation and characterization of 4-HT1A, 5-HT1B and 5-HT1C binding sites in rat frontal cortex
8. 3H]-5-carboxamidotryptamine labels 5-HT1D binding sites in bovine substantia nigra
9. Affinities of fluoxetine, its enantiomers, and other inhibitors of serotonin uptake for subtypes of serotonin receptors
10. A method for radioligand binding assays using a robotic workstation
11. Binding of antidepressants to human brain receptors: Focus on newer generation compounds
12. Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT
13. The binding of serotonergic ligands to the porcine choroid plexus: Characterization of a new type of serotonin recognition site
14. LIGAND: A versatile computerized approach for characterization of ligand-binding systems
15. Log-normal distribution of equieffective doses of norepinephrine and acetylcholine in several tissues
16. Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes
17. Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells
18. Anti-muscarinic properties of neuroleptics and drug-induced parkinsonism
19. Antischizophrenic drugs and brain cholinergic receptors - Affinity for muscarinic sites predicts extrapyramidal effects
20. 2 receptors of normal human brain in vitro
21. Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: A [35S]GTPgammaS binding study
22. Radioreceptor binding profile of the atypical antipsychotic olanzapine
23. Clozapine increases dopamine release in prefrontal cortex by 5-H(1)A receptor activation
24. Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors
25. Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects
26. Options for the treatment of negative symptoms of schizophrenia
27. Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia
28. Impact of clozapine on negative symptoms and on the deficit syndrome in refractory schizophrenia
29. 2 pK(i) values
30. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine
31. 4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs
32. Clozapine: Selective labeling of sites resembling 5HT(6) serotonin receptors may reflect psychoactive profile
33. Clozapine is a potent and selective muscarinic M(4) receptor agonist
34. Muscarinic m4 receptor activation by some atypical antipsychotic drugs
35. Typical and atypical neuroleptics: Differential effects of chronic administration of the activity of A9 and A10 midbrain dopaminergic neurons
36. Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons
37. Clozapine: Dopamine D-1 receptor agonism in the prefrontal cortex as the code to decipher a rosetta stone of antipsychotic drugs
38. Putting the 'A' in atypical: Does alpha(2)-adrenoceptor antagonism account for the therapeutic advantage of new antipsychotics?
39. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors
40. 2 receptors
41. Olanzapine